Nexus AG (NXU.DE)
EUR 68.7
(0.0%)
EUR 68.7
(0.0%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 53.43 Million EUR | 19.57% |
| 2022 | 44.81 Million EUR | 9.95% |
| 2021 | 40.77 Million EUR | 20.59% |
| 2020 | 36.69 Million EUR | 8.46% |
| 2019 | 33.97 Million EUR | 17.31% |
| 2018 | 26.62 Million EUR | 11.93% |
| 2017 | 23.68 Million EUR | 12.78% |
| 2016 | 21.05 Million EUR | 10.71% |
| 2015 | 18.94 Million EUR | 23.31% |
| 2014 | 15.33 Million EUR | 6.77% |
| 2013 | 13.83 Million EUR | 18.38% |
| 2012 | 12.34 Million EUR | 9.68% |
| 2011 | 10.94 Million EUR | 15.59% |
| 2010 | 9.04 Million EUR | 25.25% |
| 2009 | 7.71 Million EUR | 14.95% |
| 2008 | 6.7 Million EUR | 15.14% |
| 2007 | 5.82 Million EUR | 40.61% |
| 2006 | 4.14 Million EUR | -57.87% |
| 2005 | 9.83 Million EUR | 56.2% |
| 2004 | 6.29 Million EUR | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q3 | 16.32 Million EUR | 21.08% |
| 2024 Q1 | 12.97 Million EUR | -12.14% |
| 2024 Q2 | 12.61 Million EUR | -2.78% |
| 2023 Q3 | 13.92 Million EUR | 21.54% |
| 2023 Q1 | 12.24 Million EUR | -9.37% |
| 2023 Q2 | 11.45 Million EUR | -6.41% |
| 2023 FY | - EUR | 19.57% |
| 2023 Q4 | 16.18 Million EUR | 16.22% |
| 2022 Q4 | 13.5 Million EUR | 29.0% |
| 2022 Q2 | 10.63 Million EUR | 4.41% |
| 2022 FY | - EUR | 9.95% |
| 2022 Q1 | 10.18 Million EUR | -22.29% |
| 2022 Q3 | 10.47 Million EUR | -1.57% |
| 2021 Q3 | 9.24 Million EUR | -0.67% |
| 2021 Q2 | 9.3 Million EUR | 2.24% |
| 2021 FY | - EUR | 20.59% |
| 2021 Q1 | 9.1 Million EUR | -55.63% |
| 2021 Q4 | 13.11 Million EUR | 41.83% |
| 2020 Q1 | 8.53 Million EUR | -18.75% |
| 2020 Q2 | 8.24 Million EUR | -3.41% |
| 2020 Q3 | 8.11 Million EUR | -1.6% |
| 2020 Q4 | 20.51 Million EUR | 152.9% |
| 2020 FY | - EUR | 8.46% |
| 2019 FY | - EUR | 17.31% |
| 2019 Q2 | 7.9 Million EUR | 4.33% |
| 2019 Q3 | 7.98 Million EUR | 1.06% |
| 2019 Q4 | 10.5 Million EUR | 31.55% |
| 2019 Q1 | 7.57 Million EUR | -3.72% |
| 2018 Q4 | 7.86 Million EUR | 21.95% |
| 2018 Q2 | 6.48 Million EUR | 11.28% |
| 2018 Q1 | 5.82 Million EUR | -23.49% |
| 2018 FY | - EUR | 11.93% |
| 2018 Q3 | 6.45 Million EUR | -0.52% |
| 2017 Q2 | 5.43 Million EUR | -0.55% |
| 2017 Q4 | 7.61 Million EUR | 44.71% |
| 2017 Q3 | 5.26 Million EUR | -3.24% |
| 2017 FY | - EUR | 12.78% |
| 2017 Q1 | 5.46 Million EUR | -14.59% |
| 2016 Q4 | 6.4 Million EUR | 24.96% |
| 2016 FY | - EUR | 10.71% |
| 2016 Q3 | 5.12 Million EUR | 10.5% |
| 2016 Q2 | 4.63 Million EUR | -5.21% |
| 2016 Q1 | 4.89 Million EUR | -10.63% |
| 2015 Q2 | 4.64 Million EUR | 6.82% |
| 2015 Q1 | 4.35 Million EUR | -14.97% |
| 2015 FY | - EUR | 23.31% |
| 2015 Q4 | 5.47 Million EUR | 22.54% |
| 2015 Q3 | 4.46 Million EUR | -3.91% |
| 2014 Q3 | 3.21 Million EUR | -7.46% |
| 2014 Q1 | 3.52 Million EUR | -14.43% |
| 2014 FY | - EUR | 6.77% |
| 2014 Q2 | 3.47 Million EUR | -1.53% |
| 2014 Q4 | 5.11 Million EUR | 59.19% |
| 2013 Q1 | 3.31 Million EUR | -21.84% |
| 2013 FY | - EUR | 18.38% |
| 2013 Q4 | 4.12 Million EUR | 15.2% |
| 2013 Q3 | 3.57 Million EUR | 8.98% |
| 2013 Q2 | 3.28 Million EUR | -0.99% |
| 2012 Q4 | 4.24 Million EUR | 52.77% |
| 2012 Q3 | 2.77 Million EUR | -10.99% |
| 2012 Q2 | 3.12 Million EUR | 6.37% |
| 2012 Q1 | 2.93 Million EUR | 0.96% |
| 2012 FY | - EUR | 9.68% |
| 2011 FY | - EUR | 15.59% |
| 2011 Q1 | 2.55 Million EUR | -44.54% |
| 2011 Q2 | 3.08 Million EUR | 20.82% |
| 2011 Q3 | 3.16 Million EUR | 2.43% |
| 2011 Q4 | 2.9 Million EUR | -8.1% |
| 2010 Q2 | 2.17 Million EUR | 0.23% |
| 2010 FY | - EUR | 25.25% |
| 2010 Q4 | 4.6 Million EUR | 91.24% |
| 2010 Q3 | 2.4 Million EUR | 10.96% |
| 2010 Q1 | 2.16 Million EUR | -0.14% |
| 2009 FY | - EUR | 14.95% |
| 2009 Q4 | 2.16 Million EUR | 11.23% |
| 2009 Q3 | 1.95 Million EUR | 11.17% |
| 2009 Q2 | 1.75 Million EUR | -4.62% |
| 2009 Q1 | 1.83 Million EUR | 0.0% |
| 2008 FY | - EUR | 15.14% |
| 2007 FY | - EUR | 40.61% |
| 2006 FY | - EUR | -57.87% |
| 2005 FY | - EUR | 56.2% |
| 2004 FY | - EUR | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| DocCheck AG | 9.38 Million EUR | -469.483% |
| CompuGroup Medical SE & Co. KGaA | 215.84 Million EUR | 75.245% |
| MeVis Medical Solutions AG | 5.12 Million EUR | -941.628% |